Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The Gander – 4 July 2019

By Mindo - 02nd Jul 2019 | 90 views

Loving wife cares for her elderly husband with alzheimers disease.

The Medical Independent blog takes a look at the more unconventional niches in science and research

An indication of Alzheimer’s disease, by gum…

A recent study has found that a bacterium associated with chronic gum disease can be detected in the brains of people with Alzheimer’s disease.

One part of the study, which was published in Science Advances, examined autopsy brain tissue from people both with and without Alzheimer’s disease. Another arm of the study saw the researchers swab P.gingivalis onto the gums of mice for a period of six weeks, once every other day.

P.gingivalis produces an enzyme called gingipains and the authors discovered that elevated levels of gingipains was present in the majority of those with clinically-confirmed Alzheimer’s disease. Traces of Porphyromonas gingivalis, which is known to cause chronic gum disease, were found in the patients with Alzheimer’s who were autopsied.

In the mouse arm of the study, P.gingivalis was found in the mice brains and the animals developed symptoms of Alzheimer’s. In addition, dying neurons and higher levels of beta amyloid protein were found in the mice compared to the control animals.

P.gingivalis is mainly found in those with gingival and periodontal infections, however, it can also be found at low levels in 25 per cent of healthy individuals with no oral disease, said the researchers.

“Further, gingipains were neurotoxic in vivo and in vitro, exerting detrimental effects on tau, a protein needed for normal neuronal function,” wrote the authors.

“To block this neurotoxicity, we designed and synthesised small-molecule inhibitors targeting gingipains.

“Gingipain inhibition reduced the bacterial load of an established P.gingivalis brain infection, blocked Ab1–42 production, reduced neuroinflammation, and rescued neurons in the hippocampus,” they added.

“These data suggest that gingipain inhibitors could be valuable for treating P.gingivalis brain colonisation and neurodegeneration in Alzheimer’s disease.”

Leave a Reply

Latest
Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read